Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
STAAR Surgical
STAA
$1.21B
| $3.41M | ﹤0.01% |
91,707
+71,301
| +349% | +$2.66M |
|
2377
Mirion Technologies
MIR
$4.05B
| $3.41M | ﹤0.01% |
307,680
+235,288
| +325% | +$2.48M |
|
2378
NeoGenomics
NEO
$2.07B
| $3.41M | ﹤0.01% |
230,901
+170,218
| +281% | +$2.66M |
|
2379
Federal Agricultural Mortgage
AGM
$2.65B
| $3.41M | ﹤0.01% |
18,172
+11,721
| +182% | +$2.24M |
|
2380
Vontier
VNT
$4.78B
| $3.4M | ﹤0.01% |
100,836
+57,728
| +134% | +$2.05M |
|
2381
Helix Energy Solutions
HLX
$1.41B
| $3.4M | ﹤0.01% |
306,482
+223,432
| +269% | +$2.46M |
|
2382
Newell Brands
NWL
$2.61B
| $3.4M | ﹤0.01% |
442,914
+131,039
| +42% | +$938K |
|
2383
Stewart Information Services
STC
$2.1B
| $3.4M | ﹤0.01% |
45,500
+35,088
| +337% | +$2.48M |
|
2384
LeMaitre Vascular
LMAT
$2.42B
| $3.4M | ﹤0.01% |
36,577
+29,180
| +394% | +$2.53M |
|
2385
Supernus Pharmaceuticals
SUPN
$2.51B
| $3.39M | ﹤0.01% |
108,788
+51,005
| +88% | +$1.59M |
|
2386
City Holding Co
CHCO
$2.06B
| $3.39M | ﹤0.01% |
28,845
+16,044
| +125% | +$1.86M |
|
|
CFLT
2387
CALL
DELISTED
Confluent
CFLT
| $3.38M | ﹤0.01% |
165,700
+139,300
| +528% | +$3.12M |
|
2388
Empire State Realty Trust
ESRT
$855M
| $3.37M | ﹤0.01% |
304,539
+173,965
| +133% | +$1.82M |
|
2389
VSE Corp
VSEC
$6.01B
| $3.37M | ﹤0.01% |
40,770
+35,744
| +711% | +$3.11M |
|
|
DVAX
2390
DELISTED
Dynavax Technologies
DVAX
| $3.37M | ﹤0.01% |
302,572
+175,118
| +137% | +$1.93M |
|
2391
Spectrum Brands
SPB
$2.1B
| $3.37M | ﹤0.01% |
35,407
+14,746
| +71% | +$1.3M |
|
2392
Cognex
CGNX
$12B
| $3.37M | ﹤0.01% |
83,107
-29,836
| -26% | -$1.27M |
|
2393
CALL
GE HealthCare
GEHC
$31.6B
| $3.36M | ﹤0.01% |
35,800
+8,800
| +33% | +$739K |
|
2394
Integra LifeSciences
IART
$1.38B
| $3.36M | ﹤0.01% |
184,903
+159,736
| +635% | +$3.7M |
|
|
MPT
2395
Medical Properties Trust
MPT
$2.79B
| $3.35M | ﹤0.01% |
573,218
+204,956
| +56% | +$1.01M |
|
2396
Phinia Inc
PHIN
$2.93B
| $3.35M | ﹤0.01% |
72,805
+56,114
| +336% | +$2.52M |
|
2397
ESAB
ESAB
$5.88B
| $3.35M | ﹤0.01% |
31,513
+10,027
| +47% | +$993K |
|
2398
Vital Farms
VITL
$518M
| $3.35M | ﹤0.01% |
95,444
+34,758
| +57% | +$1.23M |
|
2399
Dream Finders Homes
DFH
$1.28B
| $3.35M | ﹤0.01% |
92,402
+28,764
| +45% | +$883K |
|
2400
PUT
Linde
LIN
$223B
| $3.34M | ﹤0.01% |
+7,000
| New | +$3.19M |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.